Quarter Financials
Recro Pharma, Inc. (REPH)
$2.09
-0.01 (-0.48%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Net Income | -3 | -4 | -2 | -3 | 1 | -7 | -12 | -2 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -253 | -250 | -246 | -243 | -240 | -241 | -234 | -223 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Capital Expenditure | -2 | -2 | -3 | -1 | -1 | -1 | -2 | -3 |
|---|
| Net PPE | 57 | 57 | 58 | 56 | 42 | 43 | 44 | 43 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | 4 | 4 | 4 | 4 | 40 | 41 | 41 | 41 |
|---|